Stay updated on ORION-01 Oregovomab & Nivolumab Clinical Trial

Sign up to get notified when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ORION-01 Oregovomab & Nivolumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for the Oregovomab and Nivolumab study is now displayed, with its study design, eligibility criteria, outcomes, and record history. It states that the study was terminated because of poor efficacy and is no longer recruiting participants.
    Difference
    56%
    Check dated 2026-11-07T14:52:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-31T15:22:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:36:58.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-17T16:22:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:16:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the expected study information with an access notice. This indicates a site access issue rather than content updates.
    Difference
    20%
    Check dated 2026-09-19T22:03:36.000Z thumbnail image

Stay in the know with updates to ORION-01 Oregovomab & Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.